Search

Brazilian Health Regulatory Agency (ANVISA) has given market authorization for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma

This guest editorial features insights from Consultant Biomedical Scientist David Norcliffe, Advanced Clinical Practitioner David Manuel, and Bernie Benson, Founder of Benson Viscometers, on selecting inflammatory markers for clinical diagnostics

Complementary technologies deliver an integrated, end-to-end clinical flow cytometry workflow for laboratories across Europe

Exploring the next phase of Alzheimer’s diagnostics from AAIC 2026

Evotec experts explain why early de-risking is more than avoiding failure, it is about helping the right drug candidates succeed

Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development

AAIC 2026 interview with Beckman Coulter Diagnostics

Connected data and traceable decisions are becoming vital in a new era of pharmaceutical development, AI, and advanced therapies

New partnership to create health innovation sandbox that will test promising new technologies and build evidence to accelerate the safe adoption of technologies, including AI, in the NHS

AI-powered genomic interpretation platform helps laboratories and healthcare systems interpret complex cases faster, reduce manual curation and scale genomic analysis

In a single measurement, the DynamiQ-X BG2300 determines calorific value, provides accurate gas composition analysis, and quantifies hydrogen sulfide

Hear how the Ocular Tissue Engineering Laboratory is addressing retinal cell culture challenges via an automated stem cell robot platform

Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, Nomaly

Zetasizer Core is the first instrument to measure DLS, SLS and DSF on a standard well plate, showing biologics teams not just whether a candidate is unstable, but the mechanisms driving it

Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery

New survey data reveals what scientists value most when sourcing chemical raw materials, and where Glentham Life Sciences is closing the gaps